Report cover image

Gut Health Supplements Market - 2023-2032

Publisher DataM Intelligence 4Market Research LLP
Published Apr 09, 2026
Length 201 Pages
SKU # DTAM21122425

Description

Gut Health Supplements Market Overview:
The Gut Health Supplements Market was valued at US$ 12,371.08 million in 2023 and is anticipated to reach US$ 21,114.60 million by 2032, at a CAGR of 0.0612 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Gut Health Supplements Market.

This report delivers a comprehensive overview of the Gut Health Supplements Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gut Health Supplements Market. The Gut Health Supplements Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2032.

Gut Health Supplements Market Scope:
By Ingredient
• Vitamins
• Botanicals
• Minerals
• Protein & Amino Acids
• Omega Fatty Acids
• Probiotics
• Others

By Dosage
• Tablet
• Capsules
• Liquid
• Powder
• Others

By Age
• Infant
• Children
• Adults
• Seniors

By Distribution Channel
• Online Retailers
• Pharmacies and Drug Stores
• Supermarkets/Hypermarkets
• Convenience Stores
• Other Distribution Channels

Key Players
• Nestlé S.A.
• Danone S.A.
• Yakult Honsha Co., Ltd.
• BioGaia AB
• Chr. Hansen A/S
• DuPont de Nemours, Inc.
• Reckitt Benckiser Group plc
• NOW Health Group, Inc.
• Jarrow Formulas, Inc.
• Probi AB

Major Highlights
This report delivers a comprehensive overview of the Gut Health Supplements Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gut Health Supplements Market. The Gut Health Supplements Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2032.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

201 Pages
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Ingredient
3.2. Snippet by Dosage
3.3. Snippet by Age
3.4. Snippet by Distribution Channel
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Adoption of Precision Probiotics Enabled by Next-Gen Microbiome Sequencing
4.1.2. Restraints
4.1.2.1. Limited Strain-Specific Clinical Validation Hindering Regulatory Approvals
4.1.3. Opportunities
4.1.4. Trends
4.1.5. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Pricing Analysis
5.2.1. Historical Price Trends
5.2.2. Future Price Forecast
5.2.3. Factors Influencing Pricing
5.2.4. Competitive Pricing Strategies
5.3. Regulatory and Tariff Analysis
5.4. Go-to-market (GTM) Strategies
5.5. Sustainability & ESG Analysis
5.6. Technological Analysis
5.7. Value Chain Analysis
5.8. DMI Opinion
6. By Ingredient
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
6.1.2. Market Attractiveness Index, By Ingredient
6.2. Vitamins*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Botanicals
6.4. Minerals
6.5. Protein & Amino Acids
6.6. Omega Fatty Acids
6.7. Probiotics
6.8. Others
7. By Dosage
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
7.1.2. Market Attractiveness Index, By Dosage
7.2. Tablet*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Capsules
7.4. Liquid
7.5. Powder
7.6. Others
8. By Age
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
8.1.2. Market Attractiveness Index, By Age
8.2. Infant*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Children
8.4. Adults
8.5. Seniors
9. By Distribution Channel
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Online Retailers*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Pharmacies and Drug Stores
9.4. Supermarkets/Hypermarkets
9.5. Convenience Stores
9.6. Other Distribution Channels
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. US
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. UK
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Poland
10.3.7.7. Russia
10.3.7.8. Belgium
10.3.7.9. The Netherlands
10.3.7.10. Luxembourg
10.3.7.11. Denmark
10.3.7.12. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Chile
10.4.7.4. Colombia
10.4.7.5. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. Japan
10.5.7.3. South Korea
10.5.7.4. India
10.5.7.5. Australia
10.5.7.6. New Zealand
10.5.7.7. SEA Countries
10.5.7.7.1. Indonesia
10.5.7.7.2. Malaysia
10.5.7.7.3. Philippines
10.5.7.7.4. Singapore
10.5.7.7.5. Thailand
10.5.7.7.6. Vietnam
10.5.7.7.7. Rest of SEA Countries
10.5.7.8. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.6.7.1. GCC Countries
10.6.7.1.1. Bahrain
10.6.7.1.2. Kuwait
10.6.7.1.3. Oman
10.6.7.1.4. Qatar
10.6.7.1.5. Saudi Arabia
10.6.7.1.6. UAE
10.6.7.2. Israel
10.6.7.3. South Africa
10.6.7.4. North Africa
10.6.7.5. Rest of Middle East and Africa
11. Competitive Landscape Analysis
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
11.4. Partner Identification Analysis
11.5. Investment & Funding Landscape
11.6. Strategic Alliances & Innovation Pipelines
12. Company Profiles
12.1. Nestlé S.A. *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Product Sales Footprint
12.1.4. Company Financial Overview
12.1.5. Key Developments
12.1.6. SWOT Analysis
12.1.7. Strategic Insights
12.2. Danone S.A.
12.3. Yakult Honsha Co., Ltd.
12.4. BioGaia AB
12.5. Chr. Hansen A/S
12.6. DuPont de Nemours, Inc.
12.7. Reckitt Benckiser Group plc
12.8. NOW Health Group, Inc.
12.9. Jarrow Formulas, Inc.
12.10. Probi AB (LIST NOT EXHAUSTIVE)
13. Appendix
13.1. About Us and Services
13.2. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us